124.204 Schedule I — substances included.
1. Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.
2. Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:
a. Acetylmethadol.
b. Allylprodine.
c. Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-
acetylmethadol, levomethadyl acetate, or LAAM).
d. Alphameprodine.
e. Alphamethadol.
f. Alpha-Methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine).
g. Benzethidine.
h. Betacetylmethadol.
i. Betameprodine.
j. Betamethadol.
k. Betaprodine.
l. Clonitazene.
m. Dextromoramide.
n. Difenoxin.
o. Diampromide.
p. Diethylthiambutene.
q. Dimenoxadol.
r. Dimepheptanol.
s. Dimethylthiambutene.
t. Dioxaphetyl butyrate.
u. Dipipanone.
v. Ethylmethylthiambutene.
w. Etonitazene.
x. Etoxeridine.
y. Furethidine.
z. Hydroxypethidine.
aa. Ketobemidone.
ab. Levomoramide.
ac. Levophenacylmorphan.
ad. Morpheridine.
ae. Noracymethadol.
af. Norlevorphanol.
ag. Normethadone.
ah. Norpipanone.
ai. Phenadoxone.
aj. Phenampromide.
ak. Phenomorphan.
al. Phenoperidine.
am. Piritramide.
an. Proheptazine.
ao. Properidine.
ap. Propiram.
aq. Racemoramide.
ar. Tilidine.
as. Trimeperidine.
at. Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2-hydroxy-2-phenethyl)-
3-methyl-4-piperidinyl]-N-phenylpropanamide).
au. Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-
phenylacetamide).
av. Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-
phenylpropanamide).
aw. Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-
phenylpropanamide).
ax. 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-
phenylpropanamide). For purposes of this opiate, “isomers” includes optical and geometric isomers.
ay. 3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-
phenylpropanamide).
az. MPPP (1-methyl-4-phenyl-4-propionoxypiperidine).
ba. Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-
piperidinyl] propanamide).
bb. PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine).
bc. Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide).
bd. AH-7921 (3,4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl]benzamide.
be. MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine).
bf. N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide. Other name:
acetyl fentanyl.
bg. N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide. Other name: Furanyl fentanyl.
bh. N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide. Other
name: Butyryl fentanyl.
bi. N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-
phenylpropionamide. Other name: beta-hydroxythiofentanyl.
bj. 3,4-Dichloro-N-[2-(dimethylamino)cyclohexyl]-N-
methylbenzamide. Other name: U-47700.
bk. N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide. Other names: 4-fluoroisobutyryl fentanyl, para-fluoroisobutyryl fentanyl.
bl. N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide.
Other names: ortho-fluorofentanyl; 2-fluorofentanyl.
bm. N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-
carboxamide. Other name: tetrahydrofuranyl fentanyl.
bn. 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide.
Other name: methoxyacetyl fentanyl.
bo. N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide. Other
names: acryl fentanyl; acryloylfentanyl.
bp. N-(1-phenethylpiperidin-4-yl)-N-
phenylcyclopropanecarboxamide. Other name: cyclopropyl fentanyl.
bq. N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide.
Other name: para-fluorobutyryl fentanyl.
br. N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
acetamide. Other name: ocfentanil.
bs. (E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide.
Other name: crotonyl fentanyl.
3. Opium derivatives. Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, their salts, isomers and salts of isomers, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:
a. Acetorphine.
b. Acetyldihydrocodeine.
c. Benzylmorphine.
d. Codeine methylbromide.
e. Codeine-N-Oxide.
f. Cyprenorphine.
g. Desomorphine.
h. Dihydromorphine.
i. Etorphine (except hydrochloride salt).
j. Heroin.
k. Hydromorphinol.
l. Methyldesorphine.
m. Methyldihydromorphine.
n. Morphine methylbromide.
o. Morphine methylsulfonate.
p. Morphine-N-Oxide.
q. Myrophine.
r. Nicocodeine.
s. Nicomorphine.
t. Normorphine.
u. Pholcodine.
v. Thebacon.
w. Drotebanol.
4. Hallucinogenic substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this subsection only, the term “isomer” includes the optical, position and geometric isomers):
a. 4-bromo-2,5-dimethoxy-amphetamine. Some trade or other names:
4-bromo-2,5-dimethoxy-a-methylphenethylamine; 4-bromo-2,5-DMA.
b. 2,5-dimethoxyamphetamine. Some trade or other names: 2,5-dimethoxy-a-
methylphenethylamine; 2,5-DMA.
c. 4-methoxyamphetamine. Some trade or other names: 4-methoxy-a-
methylphenethylamine; paramethoxyamphetamine, PMA.
d. 5-methoxy-3,4-methylenedioxy-amphetamine.
e. 4-methyl-2,5-dimethoxyl-amphetamine. Some trade or other names: 4-methyl-2,5-
dimethoxy-a-methylphenethylamine; “DOM”; and “STP”.
f. 3,4-methylenedioxy amphetamine, also known as MDA.
g. 3,4,5-trimethoxy amphetamine.
h. Bufotenine. Some trade or other names: 3-(B-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N,N-
dimethyltryptamine; mappine.
i. Diethyltryptamine. Some trade or other names: N,N-Diethyltryptamine; DET.
j. Dimethyltryptamine. Some trade or other names: DMT.
k. Ibogaine. Some trade or other names: 7-Ethyl-6,6B,7,8,9,10,12,13-octahydro-2-
methoxy-6,9-methano-5H-pyrido [1’,2’:1,2] azepino [5,4-b] indole; Tabernanthe iboga.
l. Lysergic acid diethylamide.
m. Marijuana, except as otherwise provided in subsection 7.
n. Mescaline.
o. Parahexyl. Some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-
trimethyl-6H-dibenzo [b,d]pyran; Synhexyl.
p. Peyote, except as otherwise provided in subsection 8. Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or extracts.
q. N-ethyl-3-piperidyl benzilate.
r. N-methyl-3-piperidyl benzilate.
s. Psilocybin.
t. Psilocyn.
u. (1) Tetrahydrocannabinols, meaning tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (Cannabis plant) as well as synthetic equivalents of the substances contained in the Cannabis plant, or in the resinous extractives of such plant, and synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following:
(a) 1 cis or trans tetrahydrocannabinol, and their optical isomers.
(b) 6 cis or trans tetrahydrocannabinol, and their optical isomers.
(c) 3,4 cis or trans tetrahydrocannabinol, and their optical isomers. (Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered.)
(2) Subparagraph (1) does not include tetrahydrocannabinol to the extent excluded in subsection 7.
v. Ethylamine analog of phencyclidine. Some trade or other names: N-ethyl-1-
phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine, N-(1-phenylcyclohexyl)
ethylamine, cyclohexamine, PCE.
w. Pyrrolidine analog of phencyclidine. Some trade or other names:
1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP.
x. Thiophene analog of phencyclidine. Some trade or other names: 1-[1-(2-thienyl)-
cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP.
y. 1-[1-(2-thienyl)cyclohexyl]pyrrolidine. Some other names: TCPy.
z. 3,4-methylenedioxymethamphetamine (MDMA).
aa. 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-
alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA).
ab. N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-
alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA).
ac. 2,5-dimethoxy-4-ethylamphet-amine. Some trade or other names: DOET.
ad. Alpha-ethyltryptamine. Some trade or other names: etryptamine; Monase; a-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; alpha-ET; and AET.
ae. 4-Bromo-2,5-dimethoxyphenethylamine. Some trade or other names: 2-(4-bromo-
2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus.
af. 2,5-dimethoxy-4-(n)-propylthiophenethylamine. Other name: 2C-T-7.
ag. Alpha-methyltryptamine. Other name: AMT.
ah. 5-methoxy-N,N-diisopropyltryptamine. Other name: 5-MeO-DIPT.
ai. (1) Salvia divinorum.
(2) Salvinorin A.
(3) HU-210. [(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-
yl) 6a,7,10,10a-tetrahydrobenzo[c] chromen-1-ol)].
(4) HU-211(dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-
methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c] chromen-1-ol).
(5) Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of cannabimimetic agents, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.
(a) The term “cannabimimetic agents” means any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist as demonstrated by binding studies and functional assays within any of the following structural classes:
(i) 2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent.
(ii) 3-(1-naphthoyl)indole or 3-(1-naphthylmethane)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.
(iii) 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent.
(iv) 1-(1-naphthylmethylene)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent.
(v) 3-phenylacetylindole or 3-benzoylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent.
(b) Such terms include:
(i) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497).
(ii) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678).
(iii) 1-butyl-3-(1-naphthoyl)indole (JWH-073).
(iv) 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200).
(v) 1-hexyl-3-(1-naphthoyl)indole (JWH-019).
(vi) 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081).
(vii) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122).
(viii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250).
(ix) RCS-4 and SR-19 1-pentyl-3-[(4methoxy)-benzoyl]indole.
(x) RCS-8 and SR 18 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole.
(xi) AM2201 1-(5-fluoropentyl)-3-(1-naphthoyl)indole.
(xii) JWH-203 1-pentyl-3-(2-chlorophenylacetyl)indole.
(xiii) JWH-398 1-pentyl-3-(4-chloro-1-naphthoyl)indole.
(xiv) AM694 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole.
(xv) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
(Cannabicyclohexanol or CP-47,497 C8-homolog).
aj. 3,4-Methylenedioxyl-N-methylcathinone (Methylone).
ak. 5-methoxy-N,N-dimethyltryptamine. Some trade or other names:
5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT.
al. 4-methyl-N-ethylcathinone. Other names: 4-MEC, 2-
(ethylamino)-1-(4-methylphenyl)propan-1-one.
am. 4-methyl-alpha-pyrrolidinopropiophenone.
Other names: 4-MePPP, MePPP, 4-methyl-[alpha]-pyrrolidinopropiophenone,
1-(4-methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one.
an. Alpha-pyrrolidinopentiophenone. Other names: [alpha]-PVP,
[alpha]-pyrrolidinovalerophenone, 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one.
ao. Butylone. Other names: bk-MBDB, 1-(1,3-benzodioxol-5-yl)-
2-(methylamino)butan-1-one.
ap. Pentedrone. Other names: [alpha]-methylaminovalerophenone,
2-(methylamino)-1-phenylpentan-1-one.
aq. Pentylone. Other names: bk-MBDP, 1-(1,3-benzodioxol-5-yl)-
2-(methylamino)pentan-1-one.
ar. 4-fluoro-N-methylcathinone. Other names: 4-FMC, flephedrone,
1-(4-fluorophenyl)-2-(methylamino)propan-1-one.
as. 3-fluoro-N-methylcathinone. Other names: 3-FMC, 1-(3-
fluorophenyl)-2-(methylamino)propan-1-one.
at. Naphyrone. Other names: naphthylpyrovalerone,
1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one.
au. Alpha-pyrrolidinobutiophenone. Other names: [alpha]-PBP,
1-phenyl-2-(pyrrolidin-1-yl)butan-1-one.
av. Marijuana extract meaning an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, containing greater than 0.3 percent tetrahydrocannabinol on a dry weight basis, other than the separated resin (whether crude or purified) obtained from the plant.
aw. Any substance, compound, mixture, or preparation which contains any quantity of any synthetic cathinone that is not approved as a pharmaceutical, including but not limited to the following:
(1) 4-methylmethcathinone (Mephedrone).
(2) 3,4-methylenedioxypyrovalerone (MDPV).
(3) 4-methoxymethcathinone (methedrone; Bk-PMMA).
(4) 3,4-methylenedioxyethcathinone (ethylone).
(5) N,N-dimethylcathinone(metamfepramone).
(6) Alpha-pyrrolidinopropiophenone (alpha-PPP).
(7) 4-methoxy-alpha-pyrrolidinopropiophenone (MOPPP).
(8) 3,4-methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP).
(9) 6,7-dihydro-5H-indeno-(5,6-d)-1,3-dioxol-6-amine) (MDAI).
(10) 3-fluoromethcathinone.
(11) 4’-Methyl-alpha-pyrrolidinobutiophenone (MPBP).
(12) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).
(13) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).
(14) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).
(15) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).
(16) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2).
(17) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4).
(18) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).
(19) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).
(20) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).
ax. (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)
methanone. Other names: UR-144, 1-pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole.
ay. [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone. Other names: 5-fluoro-UR-144, 5-F-UR-144, XLR11, 1-
(5-fluoro-pentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole.
az. N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide.
Other names: APINACA, AKB48.
ba. 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)
ethanamine. Other names: 25I-NBOMe,2C-I-NBOMe, 25I, Cimbi-5.
bb. 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)
ethanamine. Other names: 25C-NBOMe,2C-C-NBOMe, 25C, Cimbi-82.
bc. 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)
ethanamine. Other names: 25B-NBOMe,2C-B-NBOMe, 25B, Cimbi-36.
bd. Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate. Other names:
PB-22, QUPIC.
be. Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate. Other
names: 5-fluoro-PB-22, 5F-PB-22.
bf. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide. Other names: AB-FUBINACA.
bg. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-
indazole-3-carboxamide. Other name: ADB-PINACA.
bh. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-
1H-indazole-3-carboxamide. Other name: AB-CHMINACA.
bi. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide. Other name: AB-PINACA.
bj. [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalene-1-yl)
methanone. Other name: THJ-2201.
bk. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-
(cyclohexylmethyl)-1H-indazole-3-carboxamide. Other names: MAB-CHMINACA;
ADB-CHMINACA.
bl. Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-
dimethylbutanoate. Other names: 5F-ADB; 5F-MDMB-PINACA.
bm. Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-
3-methylbutanoate. Other name: 5F-AMB.
bn. N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-
carboxamide. Other names: 5F-APINACA, 5F-AKB48.
bo. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-
1H-indazole-3-carboxamide. Other name: ADB-FUBINACA.
bp. Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-
dimethylbutanoate. Other names: MDMB-CHMICA, MMB-CHMINACA.
bq. Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-
dimethylbutanoate. Other name: MDMB-FUBINACA.
br. Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-
methylbutanoate. Other names: FUB-AMB, MMB-FUBINACA, AMB-FUBINACA.
5. Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, their salts, isomers, and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
a. Mecloqualone.
b. Methaqualone.
c. Gamma-hydroxybutyric acid. Some trade or other names: GHB;
gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate;
sodium oxybutyrate.
6. Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substance having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
a. Fenethylline.
b. N-ethylamphetamine.
c. (+-)cis-4-methylaminorex ((+-)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine).
d. N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine;
N,N-alpha-trimethylphenethylamine).
e. Cathinone. Some trade or other names: 2-amino-1-phenyl-1-propanone, alpha-
aminopropiophenone, 2-aminopropiophenone, and norephedrone.
f. Aminorex. Some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline;
4,5-dihydro-5-phenyl-2-oxazolamine.
g. Methcathinone, its salts, optical isomers, and salts of optical isomers.
Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone;
2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone;
monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464;
AL-422; AL-463; and UR1432.
h. N-Benzylpiperazine. Some other names: BZP, 1-benzylpiperazine.
7. Exclusions. This section does not apply to any of the following:
a. Hemp as defined in section 204.2 that is or was produced in this state, or was produced in another state, in accordance with the provisions of chapter 204 with a maximum delta-9 tetrahydrocannabinol concentration that does not exceed three-tenths of one percent on a dry weight basis.
b. A hemp product as provided in chapter 204 with a maximum tetrahydrocannabinol concentration that does not exceed three-tenths of one percent on a dry weight basis.
8. Peyote. Nothing in this chapter shall apply to peyote when used in bona fide religious ceremonies of the Native American Church; however, persons supplying the product to the church shall register, maintain appropriate records of receipts and disbursements of peyote, and otherwise comply with all applicable requirements of this chapter and rules adopted pursuant thereto.
9. Other substances. Any material, compound, mixture, or preparation which contains any quantity of the following substances or their optical, positional, and geometric isomers, salts, and salts of isomers:
a. 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one. Other names:
N-ethylpentylone or ephylone.
b. 2-(ethylamino)-1-phenylhexan-1-one). Other name: N-Ethylhexedrone.
c. Alpha-Pyrrolidinohexanophenone. Other names: alpha-PHP; alpha-
pyrrolidinohexiophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one.
d. 4-Methyl-alpha-ethylaminopentiophenone. Other names: 4-MEAP; 2-(ethylamino)-1-
(4-methylphenyl)pentan-1-one.
e. 4’-Methyl-alpha-pyrrolidinohexiophenone. Other names: MPHP; 4’-methyl-alpha-
pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one.
f. alpha-Pyrrolidinoheptaphenone. Other names:
PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one.
g. 4’-Chloro-alpha-pyrrolidinovalerophenone. Other names: 4-chloro-alpha-PVP; 4’-
chloro-alpha-pyrrolidinopentiophenonoe; 1-(4-chlorphenyl)-2-(pyrrolidin-1-yl)pentan-
1-one.
h. N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide. Other name: valeryl fentanyl.
i. N-(4-methyoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butryamide. Other name: para-
methoxybutyryl fentanyl.
j. N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide. Other name: para-
chloroisobutyryl fentanyl.
k. N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide. Other name: isobutyryl
fentanyl.
l. N-(1-phenethylpiperidin-4-yl)-N-phenylcylopentanecarboxamide. Other name:
cyclopentyl fentanyl.
m. Fentanyl-related substances. “Fentanyl-related substance” means any substance not otherwise listed under this schedule or another schedule, and for which no exemption or approval is in effect under section 505 of the federal Food, Drug, and Cosmetic Act that is structurally related to fentanyl by one or more of the following modifications:
(1) Replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle.
(2) Substitution in or on the phenethyl group with alkyl, alkenyl, akloxyl, hydroxyl, halo, haloalkyl, amino, or nitro groups.
(3) Substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino, or nitro groups.
(4) Replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle.
(5) Replacement of the N-propionyl group by another acyl group.
n. Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate. Other names: NM2201; CBL2201.
o. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide.
Other name: 5F-AB-PINACA.
p. 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide. Other names:
4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA;
CUMYL-4CN-BINACA; SGT-78.
q. Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate. Other
names: MMB-CHMICA; AMB-CHMICA.
r. 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide.
Other name: 5F-CUMYL-P7AICA.
s. Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate. Other
name: 5F-EDMB-PINACA.
t. Methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate. Other
name: 5F-MDMB-PICA.
u. N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide. Other names:
FUB-AKB48; FUB-APINACA, ADKB48 N-(4-FLUOROBENZYL).
v. 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide. Other names:
5F-CUMYL-PINACA; SGT-25.
w. (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone. Other
name: FUB-144.
x. N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine.
Other names: isotonitazene; N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]-5-nitro-1H-
benzimidzole-1-ethanamine.*
[C73, 75, 77, 79, 81, §204.204; 82 Acts, ch 1044, §1, 2]
84 Acts, ch 1013, §4 – 8; 85 Acts, ch 86, §1, 2; 86 Acts, ch 1037, §1, 2; 87 Acts, ch 122, §1; 88 Acts, ch 1024, §1; 89 Acts, ch 109, §1, 2; 91 Acts, ch 8, §2
C93, §124.204
94 Acts, ch 1009, §2 – 8; 2000 Acts, ch 1140, §2 – 4; 2001 Acts, ch 58, §1; 2003 Acts, ch 53, §1 – 3; 2007 Acts, ch 8, §2 – 7; 2007 Acts, ch 10, §9 – 11; 2011 Acts, ch 131, §134 – 136; 2011 Acts, ch 134, §18, 27, 28; 2012 Acts, ch 1021, §122, 123, 141, 145, 146; 2012 Acts, ch 1122, §1, 8, 9, 11; 2014 Acts, ch 1056, §1, 2; 2016 Acts, ch 1081, §1, 2; 2017 Acts, ch 27, §1, 2, 11; 2017 Acts, ch 145, §28; 2018 Acts, ch 1138, §28, 31; 2019 Acts, ch 130, §22, 23, 33; 2020 Acts, ch 1023, §2 – 7, 13; 2021 Acts, ch 80, §61, 62; 2021 Acts, ch 93, §1 – 19, 38
Referred to in §29B.107A, 124.101, 124.201, 124.201A, 124.202, 124.303, 124.401, 124.410, 124.411, 124.506A, 321J.1, 411.6
*The chemical name “N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidzole-1-ethanamine” probably intended; corrective legislation is pending
See Code editor’s note on simple harmonization at the beginning of this Code volume
Subsection 2, paragraphs f and az stricken and rewritten
Subsection 2, NEW paragraphs bf – bs
Subsection 4, unnumbered paragraph 1 amended
Subsection 4, paragraphs h, i, and k stricken and rewritten
Subsection 4, paragraph m amended
Subsection 4, paragraphs o, v, x, ac, and ad stricken and rewritten
Subsection 4, paragraph ai, subparagraph (5), subparagraph division (b), subparagraph subdivisions (i) – (viii) and (xv) stricken and rewritten
Subsection 4, paragraph aj stricken and rewritten
Subsection 4, NEW paragraphs av – br
Subsection 6, paragraph h stricken and rewritten
Subsection 6, paragraph i stricken
Subsection 7 amended
Subsection 9 stricken and rewritten
Structure Iowa Code
Chapter 124 - CONTROLLED SUBSTANCES
Section 124.101 - Definitions.
Section 124.101A - Administration of controlled substances — delegation.
Section 124.101B - Factors indicating an imitation controlled substance.
Section 124.201 - Duty to recommend changes in schedules — temporary amendments to schedules.
Section 124.201A - Cannabis-derived products — rules.
Section 124.202 - Controlled substances — listed regardless of name.
Section 124.203 - Substances listed in schedule I — criteria.
Section 124.204 - Schedule I — substances included.
Section 124.205 - Substances listed in schedule II — criteria.
Section 124.206 - Schedule II — substances included.
Section 124.207 - Substances listed in schedule III — criteria.
Section 124.208 - Schedule III — substances included.
Section 124.209 - Substances listed in schedule IV — criteria.
Section 124.210 - Schedule IV — substances included.
Section 124.211 - Schedule V — criteria.
Section 124.212 - Schedule V — substances included.
Section 124.212B - Pseudoephedrine sales — tracking — penalty.
Section 124.212C - Pseudoephedrine advisory council — electronic monitoring.
Section 124.213 - Pseudoephedrine purchase restrictions from pharmacy or retailer — penalty.
Section 124.302 - Registration requirements.
Section 124.303 - Registration.
Section 124.304 - Revocation, suspension, or restriction of registration.
Section 124.305 - Contested case proceedings.
Section 124.306 - Records of registrants.
Section 124.307 - Order forms.
Section 124.308 - Prescriptions.
Section 124.401C - Manufacturing methamphetamine in presence of minors.
Section 124.401G - Iowa hemp Act — negligent violation program.
Section 124.402 - Prohibited acts — distributors — registrants — proprietors — penalties.
Section 124.404 - Penalties under other laws.
Section 124.405 - Bar to prosecution.
Section 124.406 - Distribution to person under age eighteen.
Section 124.406A - Use of persons under age eighteen in the drug trade.
Section 124.407 - Gatherings where controlled substances unlawfully used — penalties.
Section 124.408 - Joint criminal trials.
Section 124.409 - Conditional discharge, commitment for treatment, and probation.
Section 124.410 - Accommodation offense.
Section 124.411 - Second or subsequent offenses.
Section 124.412 - Notice of conviction.
Section 124.413 - Mandatory minimum sentence — parole eligibility.
Section 124.414 - Drug paraphernalia.
Section 124.415 - Parental and school notification — persons under eighteen years of age.
Section 124.416 - Exception to restrictions on bail.
Section 124.417 - Imitation controlled substances — exceptions.
Section 124.418 - Persons seeking medical assistance for drug-related overdose.
Section 124.501 - Responsibility for enforcement.
Section 124.502 - Administrative inspections and warrants.
Section 124.503 - Injunctions.
Section 124.504 - Cooperative arrangements and confidentiality.
Section 124.506 - Controlled substances — disposal.
Section 124.506A - Large seizure of a controlled substance — evidence and disposal.
Section 124.507 - Burden of proof — liabilities.
Section 124.508 - Judicial review.
Section 124.509 - Education and research.
Section 124.510 - Reports of arrests and analyses to department.
Section 124.550 - Definitions.
Section 124.551 - Information program for drug prescribing and dispensing.
Section 124.551A - Prescribing practitioner program registration.
Section 124.552 - Information reporting.
Section 124.553 - Information access.
Section 124.554 - Rules and reporting.
Section 124.555 - Advisory council established.
Section 124.556 - Education and treatment.
Section 124.557 - Drug information program fund — surcharge.
Section 124.558 - Prohibited acts — penalties.